These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
√
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2010
OR
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____________
|
|
Delaware
|
20-3340900
|
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
(IRS Employer Identification No.)
|
|
Large accelerated filer
|
Accelerated filer √
|
|
Non-accelerated filer
(do not check if a smaller reporting company)
|
Smaller reporting company
|
|
(Unaudited) September 30,
2010
|
December 31, 2009
|
|||||||
|
Assets
|
||||||||
|
Cash and cash equivalents
|
$ | 103,535 | $ | 65,512 | ||||
|
Accounts receivable, net of allowances of $-
|
26,850 | 21,759 | ||||||
|
Inventory
|
31,298 | 26,444 | ||||||
|
Income taxes receivable
|
1,521 | 912 | ||||||
|
Prepaid expenses
|
302 | 1,297 | ||||||
|
Prepaid expenses – related parties
|
- | 23 | ||||||
|
Marketable and auction rate securities
|
26,756 | 6,811 | ||||||
|
Other current assets
|
796 | 828 | ||||||
|
Total current assets
|
191,058 | 123,586 | ||||||
|
Property, plant and equipment, net
|
121,611 | 119,248 | ||||||
|
Intangible assets
|
123 | 208 | ||||||
|
Other assets
|
2,408 | 2,965 | ||||||
|
Total noncurrent assets
|
124,142 | 122,421 | ||||||
|
Total Assets
|
$ | 315,200 | $ | 246,007 | ||||
|
Liabilities and Stockholders’ Equity
|
||||||||
|
Accounts payable
|
$ | 12,413 | $ | 14,269 | ||||
|
Accounts payable - related parties
|
210 | 556 | ||||||
|
Current deferred income tax liability
|
4,332 | 3,172 | ||||||
|
Deferred revenue – short term
|
1,094 | - | ||||||
|
Accrued expenses and other current liabilities
|
4,970 | 2,832 | ||||||
|
Accrued expenses and other current liabilities - related parties
|
22 | 67 | ||||||
|
Total current liabilities
|
23,041 | 20,896 | ||||||
|
Deferred revenue – long term
|
13,505 | 9,348 | ||||||
|
Contingent liability
|
1,997 | - | ||||||
|
Other noncurrent liabilities
|
896 | 1,376 | ||||||
|
Noncurrent deferred income tax liability
|
25,460 | 24,118 | ||||||
|
Total noncurrent liabilities
|
41,858 | 34,842 | ||||||
|
Total Liabilities
|
64,899 | 55,738 | ||||||
|
Commitments and contingencies
|
||||||||
|
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding
|
- | - | ||||||
|
Common stock, $0.0001 par value, 75,000,000 shares authorized, 39,973,849 and 28,190,300 shares issued and outstanding as of September 30, 2010 and December 31, 2009, respectively
|
4 | 3 | ||||||
|
Accumulated other comprehensive income
|
663 | 38 | ||||||
|
Additional paid in capital
|
237,088 | 167,598 | ||||||
|
Retained earnings
|
12,546 | 22,630 | ||||||
|
Total stockholders’ equity
|
250,301 | 190,269 | ||||||
|
Total Liabilities and Stockholders’ Equity
|
$ | 315,200 | $ | 246,007 | ||||
|
Three Months Ended
September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Revenues
|
$ | 66,093 | $ | 52,263 | ||||
|
Cost of goods sold
|
52,457 | 36,839 | ||||||
|
Cost of goods sold – related parties
|
696 | 635 | ||||||
|
Distribution
|
858 | 1,139 | ||||||
|
Distribution – related parties
|
206 | - | ||||||
|
Gross profit
|
11,876 | 13,650 | ||||||
|
Selling, general and administrative expenses
|
||||||||
|
Compensation expense
|
808 | 729 | ||||||
|
Other expense
|
697 | 382 | ||||||
|
Related party expense
|
35 | 43 | ||||||
|
Research and development expenses
|
800 | 1,111 | ||||||
| 2,340 | 2,265 | |||||||
|
Income from operations
|
9,536 | 11,385 | ||||||
|
Investment income
|
307 | 36 | ||||||
|
Interest expense
|
(8 | ) | (5 | ) | ||||
|
Gain on sale of marketable securities
|
67 | - | ||||||
|
Other income
|
99 | 12 | ||||||
| 465 | 43 | |||||||
|
Income before income taxes
|
10,001 | 11,428 | ||||||
|
Provision for income taxes
|
3,450 | 4,044 | ||||||
|
Net income
|
$ | 6,551 | $ | 7,384 | ||||
|
Earnings per common share
|
||||||||
|
Basic
|
$ | 0.16 | $ | 0.26 | ||||
|
Diluted
|
$ | 0.16 | $ | 0.25 | ||||
|
Weighted average shares outstanding
|
||||||||
|
Basic
|
39,934,275 | 28,190,300 | ||||||
|
Diluted
|
40,028,131 | 29,191,106 | ||||||
|
Comprehensive Income
|
||||||||
|
Net income
|
$ | 6,551 | $ | 7,384 | ||||
|
Other comprehensive income, net of tax of $346 in 2010 and $- in 2009
|
564 | - | ||||||
|
Comprehensive income
|
$ | 7,115 | $ | 7,384 | ||||
|
Nine Months Ended
September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Revenues
|
$ | 165,570 | $ | 132,939 | ||||
|
Revenues – related parties
|
- | 892 | ||||||
|
Cost of goods sold
|
133,411 | 101,464 | ||||||
|
Cost of goods sold – related parties
|
3,058 | 3,132 | ||||||
|
Distribution
|
2,561 | 3,357 | ||||||
|
Distribution – related parties
|
421 | - | ||||||
|
Gross profit
|
26,119 | 25,878 | ||||||
|
Selling, general and administrative expenses
|
||||||||
|
Compensation expense
|
2,270 | 2,021 | ||||||
|
Other expense
|
1,602 | 1,278 | ||||||
|
Related party expense
|
105 | 156 | ||||||
|
Research and development expenses
|
2,586 | 3,110 | ||||||
| 6,563 | 6,565 | |||||||
|
Income from operations
|
19,556 | 19,313 | ||||||
|
Investment income
|
651 | 325 | ||||||
|
Interest expense
|
(19 | ) | (19 | ) | ||||
|
Gain (loss) on foreign currency
|
- | (3 | ) | |||||
|
Gain on the sale of marketable securities
|
63 | - | ||||||
|
Other income (expense)
|
141 | (7 | ) | |||||
| 836 | 296 | |||||||
|
Income before income taxes
|
20,392 | 19,609 | ||||||
|
Provision for income taxes
|
7,419 | 6,554 | ||||||
|
Net income
|
$ | 12,973 | $ | 13,055 | ||||
|
Earnings per common share
|
||||||||
|
Basic
|
$ | 0.37 | $ | 0.46 | ||||
|
Diluted
|
$ | 0.36 | $ | 0.46 | ||||
|
Weighted average shares outstanding
|
||||||||
|
Basic
|
35,363,531 | 28,190,300 | ||||||
|
Diluted
|
36,207,117 | 28,529,213 | ||||||
|
Comprehensive Income
|
||||||||
|
Net income
|
$ | 12,973 | $ | 13,055 | ||||
|
Other comprehensive income (loss), net of tax of $382 in 2010 and $(9) in 2009
|
625 | (15 | ) | |||||
|
Comprehensive income
|
$ | 13,598 | $ | 13,040 | ||||
|
Nine Months Ended
September 30,
|
||||||||
|
2010
|
2009
|
|||||||
|
Cash flows provided by operating activities
|
||||||||
|
Net income
|
$ | 12,973 | $ | 13,055 | ||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation
|
5,637 | 5,545 | ||||||
|
Provision for deferred income taxes
|
2,889 | 400 | ||||||
|
Change in fair value of derivative instruments
|
488 | (1,322 | ) | |||||
|
Gain on the sale of investments
|
(63 | ) | - | |||||
|
(Gains) losses on disposals of fixed assets
|
143 | (2 | ) | |||||
|
Noncash interest expense
|
17 | 16 | ||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
(5,091 | ) | (3,086 | ) | ||||
|
Accounts receivable – related parties
|
- | (24 | ) | |||||
|
Inventory
|
(4,854 | ) | (3,760 | ) | ||||
|
Income taxes receivable
|
(609 | ) | 792 | |||||
|
Prepaid expenses
|
995 | 853 | ||||||
|
Prepaid expenses – related parties
|
23 | - | ||||||
|
Accrued interest on marketable debt securities
|
(9 | ) | 5 | |||||
|
Other assets
|
324 | (201 | ) | |||||
|
Accounts payable
|
(1,856 | ) | (1,304 | ) | ||||
|
Accounts payable – related parties
|
(346 | ) | (269 | ) | ||||
|
Income taxes payable
|
- | 2,576 | ||||||
|
Accrued expenses and other current liabilities
|
2,138 | 2,660 | ||||||
|
Accrued expenses and other current liabilities – related parties
|
(45 | ) | - | |||||
|
Deferred revenue
|
5,252 | (578 | ) | |||||
|
Other noncurrent liabilities
|
(497 | ) | 101 | |||||
|
Net cash provided by operating activities
|
17,509 | 15,457 | ||||||
|
Cash flows from investing activities
|
||||||||
|
Collateralization of derivative instruments
|
(992 | ) | 5,719 | |||||
|
Purchase of marketable securities
|
(20,199 | ) | (19,999 | ) | ||||
|
Proceeds from the sale of marketable securities
|
1,333 | 35,972 | ||||||
|
Sales of auction rate securities, net
|
- | 12,185 | ||||||
|
Proceeds from the sale of commercial paper
|
- | 15,424 | ||||||
|
Proceeds from the sale of fixed assets
|
2 | 17 | ||||||
|
Acquisition of a granary
|
- | (1,252 | ) | |||||
|
Contingent purchase price payment
|
- | (282 | ) | |||||
|
Capital expenditures
|
(6,063 | ) | (17,177 | ) | ||||
|
Net cash provided by (used in) investing activities
|
(25,919 | ) | 30,607 | |||||
|
Cash flows from financing activities
|
||||||||
|
Proceeds from the issuance of stock
|
70,700 | - | ||||||
|
Purchase of warrants
|
(1,210 | ) | (385 | ) | ||||
|
Payment of dividend
|
(23,057 | ) | - | |||||
|
Net cash provided by (used in) financing activities
|
46,433 | (385 | ) | |||||
|
Net change in cash and cash equivalents
|
38,023 | 45,679 | ||||||
|
Cash and cash equivalents at beginning of period
|
65,512 | 27,455 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 103,535 | $ | 73,134 | ||||
|
Cash paid for interest
|
$ | 2 | $ | 5 | ||||
|
Cash paid for taxes
|
$ | 6,605 | $ | 2,922 | ||||
|
September 30,
2010
|
December 31, 2009
|
|||||||
|
At first-in, first-out or average cost (approximates current cost)
|
||||||||
|
Finished goods
|
$ | 5,294 | $ | 14,078 | ||||
|
Work in process
|
1,511 | 1,841 | ||||||
|
Raw materials and supplies
|
30,255 | 16,451 | ||||||
| 37,060 | 32,370 | |||||||
|
LIFO reserve
|
(5,762 | ) | (5,926 | ) | ||||
|
Total inventories
|
$ | 31,298 | $ | 26,444 | ||||
|
Asset/(Liability)
|
||||||||||||||||
|
September 30, 2010
|
December 31, 2009
|
|||||||||||||||
|
Quantity (Contracts) Long/
(Short)
|
Fair Value
|
Quantity (Contracts) Long/
(Short)
|
Fair Value
|
|||||||||||||
|
Regulated fixed price future commitments, included in other current assets
|
(28 | ) | $ | (131 | ) | 10 | $ | 68 | ||||||||
|
Regulated options, included in other current assets
|
(200 | ) | $ | (3,056 | ) | (150 | ) | $ | (1,998 | ) | ||||||
|
September 30,
2010
|
December 31, 2009
|
|||||||
|
Accrued employee liabilities
|
$ | 3,355 | $ | 1,499 | ||||
|
Accrued property, use, and franchise taxes
|
1,033 | 1,064 | ||||||
|
Other
|
604 | 336 | ||||||
|
Total
|
$ | 4,992 | $ | 2,899 | ||||
|
Leverage
Ratio
|
Base Rate
Margin
|
LIBOR
Margin
|
||
|
> 3
|
-0.55%
|
1.70%
|
||
|
>
2 < 3
|
-0.70%
|
1.55%
|
||
|
>
1 < 2
|
-0.85%
|
1.40%
|
||
|
< 1
|
-1.00%
|
1.25%
|
|
For the three months ended September 30,
|
For the nine months ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Provision for income taxes
|
$ | 3,450 | $ | 4,044 | $ | 7,419 | $ | 6,554 | ||||||||
|
Effective tax rate
|
34.5 | % | 35.4 | % | 36.4 | % | 33.4 | % | ||||||||
|
For the three months ended September 30,
|
For the nine months ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Net income available to common stockholders
|
$ | 6,551 | $ | 7,384 | $ | 12,973 | $ | 13,055 | ||||||||
|
Weighted average number of common shares outstanding
|
39,934,275 | 28,190,300 | 35,363,531 | 28,190,300 | ||||||||||||
|
Effect of warrants
|
61,809 | 977,076 | 814,488 | 325,692 | ||||||||||||
|
Effect of stock options
|
32,047 | 23,730 | 29,098 | 13,221 | ||||||||||||
|
Weighted average diluted number of common shares outstanding
|
40,028,131 | 29,191,106 | 36,207,117 | 28,529,213 | ||||||||||||
|
Basic earnings per share
|
$ | 0.16 | $ | 0.26 | $ | 0.37 | $ | 0.46 | ||||||||
|
Diluted earnings per share
|
$ | 0.16 | $ | 0.25 | $ | 0.36 | $ | 0.46 | ||||||||
|
Three Months Ended
|
United States
|
All Foreign Countries
|
Total
|
|||||||||
|
September 30, 2010
|
$ | 61,987 | $ | 4,106 | $ | 66,093 | ||||||
|
September 30, 2009
|
$ | 48,007 | $ | 4,256 | $ | 52,263 | ||||||
|
Nine Months Ended
|
United States
|
All Foreign Countries
|
Total
|
|||||||||
|
September 30, 2010
|
$ | 151,927 | $ | 13,643 | $ | 165,570 | ||||||
|
September 30, 2009
|
$ | 120,636 | $ | 13,195 | $ | 133,831 | ||||||
|
For the three months ended September 30,
|
For the nine months ended September 30,
|
|||||||||||||||
|
2010
|
2009
|
2010
|
2009
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
Chemicals
|
$ | 47,209 | $ | 39,029 | $ | 131,066 | $ | 102,745 | ||||||||
|
Biofuels
|
18,884 | 13,234 | 34,504 | 31,086 | ||||||||||||
|
Total revenues
|
$ | 66,093 | $ | 52,263 | $ | 165,570 | $ | 133,831 | ||||||||
|
Segment gross margins
|
||||||||||||||||
|
Chemicals
|
$ | 13,289 | $ | 7,929 | $ | 31,221 | $ | 21,635 | ||||||||
|
Biofuels
|
(1,413 | ) | 5,721 | (5,102 | ) | 4,243 | ||||||||||
|
Segment gross margins
|
11,876 | 13,650 | 26,119 | 25,878 | ||||||||||||
|
Corporate expenses
|
(2,340 | ) | (2,265 | ) | (6,563 | ) | (6,565 | ) | ||||||||
|
Income before interest and taxes
|
9,536 | 11,385 | 19,556 | 19,313 | ||||||||||||
|
Interest and other income
|
473 | 48 | 855 | 325 | ||||||||||||
|
Interest and other expense
|
(8 | ) | (5 | ) | (19 | ) | (29 | ) | ||||||||
|
Provision for income taxes
|
(3,450 | ) | (4,044 | ) | (7,419 | ) | (6,554 | ) | ||||||||
|
Net income
|
$ | 6,551 | $ | 7,384 | $ | 12,973 | $ | 13,055 | ||||||||
|
Asset/(Liability)
|
||||||||||||||||
|
Fair Value at September 30,
|
Fair Value Measurements Using
Inputs Considered as
|
|||||||||||||||
|
Description
|
2010
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
Available for sale:
|
||||||||||||||||
|
Auction rate securities
|
$ | 2,800 | $ | - | $ | 2,800 | $ | - | ||||||||
|
Preferred stock and trust preferred securities
|
$ | 16,481 | $ | 16,481 | $ | - | $ | - | ||||||||
|
Master limited partnerships
|
$ | 7,475 | $ | 7,475 | $ | - | $ | - | ||||||||
|
Derivative instruments
|
$ | (3,187 | ) | $ | (3,187 | ) | $ | - | $ | - | ||||||
|
Asset/(Liability)
|
||||||||||||||||
|
Fair Value at December 31,
|
Fair Value Measurements Using
Inputs Considered as
|
|||||||||||||||
|
Description
|
2009
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
Available for sale:
|
||||||||||||||||
|
Auction rate securities
|
$ | 2,800 | $ | - | $ | 2,800 | $ | - | ||||||||
|
Preferred stock and trust preferred securities
|
$ | 4,011 | $ | 4,011 | $ | - | $ | - | ||||||||
|
Derivative instruments
|
$ | (1,930 | ) | $ | (1,930 | ) | $ | - | $ | - | ||||||
|
Nine Months Ended September 30,
2010
|
Nine Months Ended September 30,
2009
|
|||||||
|
Net cash provided by operating activities
|
$ | 17,509 | $ | 15,457 | ||||
|
Net cash provided by (used in) investing activities
|
$ | (25,919 | ) | $ | 30,607 | |||
|
Net cash provided by (used in) financing activities
|
$ | 46,433 | $ | (385 | ) | |||
|
Item
|
Volume
(a)
Requirements
|
Units
|
Hypothetical
Adverse
Change in
Price
|
Decrease in
Gross Profit
|
Percentage
Decrease in
Gross Profit
|
|||||
|
Biodiesel
feedstock
|
47,245,494
|
LB
|
10.0%
|
$ 1,380
|
5.3%
|
|
(a)
|
Volume requirements and average price information are based upon volumes used and prices obtained for the nine months ended September 30, 2010. Volume requirements may differ materially from these quantities in future years as our business evolves.
|
|
Exhibit No.
|
Description
|
|
31(a)
|
Rule 13a-15(e)/15d-15(e) Certification of chief executive officer
|
|
31(b)
|
Rule 13a-15(e)/15d-15(e) Certification of principal financial officer
|
|
32
|
Section 1350 Certification of chief executive officer and principal financial officer
|
|
·
|
conflicts of interest of our officers and directors;
|
|
·
|
potential future affiliations of our officers and directors with competing businesses;
|
|
·
|
the control by our founding shareholders of a substantial interest in us;
|
|
·
|
the highly competitive nature of the chemical and alternative fuel industries;
|
|
·
|
fluctuations in energy prices may cause a reduction in the demand or profitability of the products or services we may ultimately produce or offer or which form a portion of our business;
|
|
·
|
changes in technology may render our products or services obsolete;
|
|
·
|
failure to comply with governmental regulations could result in the imposition of penalties, fines or restrictions on operations and remedial liabilities;
|
|
·
|
our biofuels business may be harmed if the applicable government were to change current laws and/or regulations;
|
|
·
|
our board may have incorrectly evaluated FutureFuel Chemical Company’s potential liabilities;
|
|
·
|
we may engage in hedging transactions in an attempt to mitigate exposure to price fluctuations in petroleum product transactions and other portfolio positions which may not ultimately be successful; and
|
|
·
|
we may not continue to have access to capital markets and commercial bank financing on favorable terms and we may lose our ability to buy on open credit terms.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|